Annals of Surgical Oncology
-
Publication Venue For
-
Treatment Patterns and Outcomes of Women with Breast Cancer and Supraclavicular Nodal Metastases..
28:2146-2154.
2021
-
ASO Author Reflections: Gene Expression-Profiling and Implications for Adjuvant Therapy in Melanoma.
2021
-
Detailed Analysis of Margin Positivity and the Site of Local Recurrence After Pancreaticoduodenectomy..
28:539-549.
2021
-
Impact of Postoperative Chemotherapy on the Survival of Patients with High-Grade Gastroenteropancreatic Neuroendocrine Carcinoma..
28:114-120.
2021
-
ASO Author Reflection: Postoperative Chemotherapy for Nonmetastatic, Poorly Differentiated Gastroenteropancreatic Neuroendocrine Carcinomas..
27:804-805.
2020
-
ASO Author Reflections: Adjuvant Therapy is Effective for Melanoma Patients with Positive Sentinel Lymph Node Biopsy Who Forgo Completion Lymphadenectomy..
27:5126-5127.
2020
-
ASO Author Reflections: Implementation of a New Hepatic Artery Infusion Program for Colorectal Liver Metastases is Safe, Feasible, and Effective..
27:5096-5097.
2020
-
ASO Author Reflections: What is the Most Appropriate Surgical Management for Men with Breast Cancer?.
27:697-698.
2020
-
Adjuvant Therapy is Effective for Melanoma Patients with a Positive Sentinel Lymph Node Biopsy Who Forego Completion Lymphadenectomy..
27:5121-5125.
2020
-
Implementation of a Hepatic Artery Infusion Program: Initial Patient Selection and Perioperative Outcomes of Concurrent Hepatic Artery Infusion and Systemic Chemotherapy for Colorectal Liver Metastases..
27:5086-5095.
2020
-
Melanomas of Unknown Primary May Have a Distinct Molecular Classification to Explain Differences in Patient Outcomes..
27:4870-4871.
2020
-
Oncologic Outcomes After Isolated Limb Infusion for Advanced Melanoma: An International Comparison of the Procedure and Outcomes Between the United States and Australia..
27:5107-5118.
2020
-
Short-Term Risk of Performing Concurrent Procedures with Hepatic Artery Infusion Pump Placement..
27:5098-5106.
2020
-
Adjuvant Radiation Therapy for Clinical Stage III Melanoma in the Modern Therapeutic Era.
2020
-
Characterization of Sentinel Lymph Node Immune Signatures and Implications for Risk Stratification for Adjuvant Therapy in Melanoma.
2020
-
Surgery for Men with Breast Cancer: Do the Same Data Still Apply?.
27:4720-4729.
2020
-
The Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In Situ in Patients with Intraductal Papilloma without Atypia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 034).
2020
-
Acral Melanomas of the Sole May Have Worse Prognosis Compared with Other Sites of Acral Melanoma..
27:3121-3122.
2020
-
"Choosing Wisely" in Breast Cancer Surgery: Drivers of Low Value Care..
27:2577-2579.
2020
-
Designing a Rational Follow-Up Schedule for Patients with Extremity Soft Tissue Sarcoma..
27:2033-2041.
2020
-
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Appendiceal Neoplasms..
27:1753-1760.
2020
-
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Colorectal Metastases..
27:1761-1767.
2020
-
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Desmoplastic Small Round Cell Tumor, Breast, and Gastrointestinal Stromal Tumors..
27:1793-1797.
2020
-
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Gastric Metastases..
27:1768-1773.
2020
-
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Neuroendocrine Tumors..
27:1788-1792.
2020
-
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Ovarian Neoplasms..
27:1780-1787.
2020
-
The Chicago Consensus on Peritoneal Surface Malignancies: Management of Peritoneal Mesothelioma..
27:1774-1779.
2020
-
The Chicago Consensus on Peritoneal Surface Malignancies: Palliative Care Considerations..
27:1798-1804.
2020
-
The Chicago Consensus on Peritoneal Surface Malignancies: Standards..
27:1743-1752.
2020
-
International Multicenter Experience of Isolated Limb Infusion for In-Transit Melanoma Metastases in Octogenarian and Nonagenarian Patients..
27:1420-1429.
2020
-
Prediction of Recurrence Patterns from Hepatic Parenchymal Disease After Resection of Colorectal Liver Metastases..
27:188-195.
2020
-
The Landmark Series: Regional Therapy of Recurrent Cutaneous Melanoma..
27:35-42.
2020
-
ASO Author Reflections: The Pressing Need for Germline Genetic Testing..
26:612-613.
2019
-
Correction to: Characteristics Associated with Pathologic Nodal Burden in Patients Presenting with Clinical Melanoma Nodal Metastasis..
26:893.
2019
-
Correction to: Factors Associated with Reoperation in Breast-Conserving Surgery for Cancer: A Prospective Study of American Society of Breast Surgeon Members..
26:891.
2019
-
Does Breast Density Increase the Risk of Re-excision for Women with Breast Cancer Having Breast-Conservation Therapy?.
26:4246-4253.
2019
-
Characteristics Associated with Pathologic Nodal Burden in Patients Presenting with Clinical Melanoma Nodal Metastasis..
26:3962-3971.
2019
-
Maintenance of Certification and Continuing Medical Education: Are They Still Required?.
26:3820-3823.
2019
-
Was Reexcision Less Frequent for Patients with Lobular Breast Cancer After Publication of the SSO-ASTRO Margin Guidelines?.
26:3856-3862.
2019
-
Factors Associated with Reoperation in Breast-Conserving Surgery for Cancer: A Prospective Study of American Society of Breast Surgeon Members..
26:3321-3336.
2019
-
Outcomes of Lymph Node Dissection for Non-metastatic Pancreatic Neuroendocrine Tumors: A Propensity Score-Weighted Analysis of the National Cancer Database..
26:2722-2729.
2019
-
A Nomogram for Predicting Cancer-Specific Survival of TNM 8th Edition Stage I Non-small-cell Lung Cancer..
26:2053-2062.
2019
-
Germline Genetic Testing: What the Breast Surgeon Needs to Know..
26:2184-2190.
2019
-
Peripheral Circulating Tumor DNA Detection Predicts Poor Outcomes After Liver Resection for Metastatic Colorectal Cancer..
26:1824-1832.
2019
-
ASO Author Reflections: Metaplastic Breast Cancer-The Case for Doing Less and More..
25:689-690.
2018
-
ASO Author Reflections: Progression after Resection of Noninvasive or Microinvasive Intraductal Papillary Mucinous Neoplasms..
25:822-823.
2018
-
Multidisciplinary Management of the Axilla in Patients with cT1-T2 N0 Breast Cancer Undergoing Primary Mastectomy: Results from a Prospective Single-Institution Series..
25:3527-3534.
2018
-
Select Choices in Benign Breast Disease: An Initiative of the American Society of Breast Surgeons for the American Board of Internal Medicine Choosing Wisely® Campaign..
25:2795-2800.
2018
-
The Association of Extent of Axillary Surgery and Survival in Women with N2-3 Invasive Breast Cancer..
25:3019-3029.
2018
-
The Changing Paradigms for Breast Cancer Surgery: Performing Fewer and Less-Invasive Operations..
25:2807-2812.
2018
-
Metaplastic Breast Cancer Treatment and Outcomes in 2500 Patients: A Retrospective Analysis of a National Oncology Database..
25:2249-2260.
2018
-
Progression Patterns in the Remnant Pancreas after Resection of Non-Invasive or Micro-Invasive Intraductal Papillary Mucinous Neoplasms (IPMN)..
25:1752-1759.
2018
-
Impact of Micro- and Macroscopically Positive Surgical Margins on Survival after Resection of Adrenocortical Carcinoma..
25:1425-1431.
2018
-
Reasons Associated with Total Thyroidectomy as Initial Surgical Management of an Indeterminate Thyroid Nodule..
25:1410-1417.
2018
-
Association of Delivery System Integration and Outcomes for Major Cancer Surgery..
25:856-863.
2018
-
Survival Prediction in Pancreatic Ductal Adenocarcinoma by Quantitative Computed Tomography Image Analysis..
25:1034-1042.
2018
-
Benchmarking the American Society of Breast Surgeon Member Performance for More Than a Million Quality Measure-Patient Encounters..
25:501-511.
2018
-
How Low Can We Go-and Should We? Risk Reduction for Minimal-Volume DCIS..
25:354-355.
2018
-
Molecular Genomic Testing for Breast Cancer: Utility for Surgeons..
25:512-519.
2018
-
The Impact of Primary Tumor Location on Long-Term Survival in Patients Undergoing Hepatic Resection for Metastatic Colon Cancer..
25:431-438.
2018
-
Treatment Patterns and Outcomes for Patients with Adrenocortical Carcinoma Associated with Hospital Case Volume in the United States: A Reply..
24:618.
2017
-
Association Between Patient Satisfaction and Short-Term Outcomes After Major Cancer Surgery..
24:3486-3493.
2017
-
Patient Age and Tumor Subtype Predict the Extent of Axillary Surgery Among Breast Cancer Patients Eligible for the American College of Surgeons Oncology Group Trial Z0011..
24:3559-3566.
2017
-
Surgical Upstaging Rates for Vacuum Assisted Biopsy Proven DCIS: Implications for Active Surveillance Trials..
24:3534-3540.
2017
-
Utility of Serum Inflammatory Markers for Predicting Microvascular Invasion and Survival for Patients with Hepatocellular Carcinoma..
24:3706-3714.
2017
-
Cost Effectiveness of Risk-Reducing Mastectomy versus Surveillance in BRCA Mutation Carriers with a History of Ovarian Cancer..
24:3116-3123.
2017
-
The American Society of Breast Surgeons and Quality Payment Programs: Ranking, Defining, and Benchmarking More Than 1 Million Patient Quality Measure Encounters..
24:3093-3106.
2017
-
Computed Tomography Image Texture: A Noninvasive Prognostic Marker of Hepatic Recurrence After Hepatectomy for Metastatic Colorectal Cancer..
24:2482-2490.
2017
-
Sentinel Lymph Node Biopsy for Recurrent Melanoma: A Multicenter Study..
24:2728-2733.
2017
-
Tumor-Associated Macrophage Infiltration in Colorectal Cancer Liver Metastases is Associated With Better Outcome..
24:1835-1842.
2017
-
Anticipatory Positive Urine Tests for Bladder Cancer..
24:1747-1753.
2017
-
Actual 10-Year Survivors After Resection of Hepatocellular Carcinoma..
24:1358-1366.
2017
-
Percutaneous Peritoneal Lavage for the Rapid Staging of Gastric and Pancreatic Cancer..
24:1174-1179.
2017
-
Clinical Utility of the 12-Gene DCIS Score Assay: Impact on Radiotherapy Recommendations for Patients with Ductal Carcinoma In Situ..
24:660-668.
2017
-
Postmastectomy Radiotherapy: An American Society of Clinical Oncology, American Society for Radiation Oncology, and Society of Surgical Oncology Focused Guideline Update..
24:38-51.
2017
-
Surgical Strategy and Outcomes in Duodenal Gastrointestinal Stromal Tumor..
24:202-210.
2017
-
Active Surveillance for DCIS: The Importance of Selection Criteria and Monitoring..
23:4134-4136.
2016
-
Clinicopathological Features and Prognosis of Mixed-Type T1a Gastric Cancer Based on Lauren's Classification..
23:784-791.
2016
-
Society of Surgical Oncology-American Society for Radiation Oncology-American Society of Clinical Oncology Consensus Guideline on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Ductal Carcinoma In Situ..
23:3801-3810.
2016
-
Early Adoption of the SSO-ASTRO Consensus Guidelines on Margins for Breast-Conserving Surgery with Whole-Breast Irradiation in Stage I and II Invasive Breast Cancer: Initial Experience from Memorial Sloan Kettering Cancer Center..
23:3239-3246.
2016
-
Factors Associated with Recurrence Rates and Long-Term Survival in Women Diagnosed with Breast Cancer Ages 40 and Younger..
23:3212-3220.
2016
-
Measures of Appropriateness and Value for Breast Surgeons and Their Patients: The American Society of Breast Surgeons Choosing Wisely (®) Initiative..
23:3112-3118.
2016
-
Neoadjuvant Systemic Therapy for Breast Cancer: Factors Influencing Surgeons' Referrals..
23:3510-3517.
2016
-
Should New "No Ink On Tumor" Lumpectomy Margin Guidelines be Applied to Ductal Carcinoma In Situ (DCIS)? A Retrospective Review Using Shaved Cavity Margins..
23:3453-3458.
2016
-
The Impact of the Affordable Care Act on North Carolinian Breast Cancer Patients Seeking Financial Support for Treatment..
23:3412-3417.
2016
-
The Use of Re-irradiation in Locally Recurrent, Non-metastatic Rectal Cancer..
23:3609-3615.
2016
-
Critical Assessment of Clinical Prognostic Tools in Melanoma..
23:2753-2761.
2016
-
Postmastectomy Radiation Treatment Rates as a Quality Measure: An Opportunity for Compliance Through Collaboration..
23:2377-2379.
2016
-
Value-Based Breast Cancer Care: A Multidisciplinary Approach for Defining Patient-Centered Outcomes..
23:2385-2390.
2016
-
Health-Related Quality of Life After Pancreatectomy: Results From a Randomized Controlled Trial..
23:2137-2145.
2016
-
Computed Tomography-Based Limb Volume Measurements for Isolated Limb Infusion in Melanoma..
23:1090-1095.
2016
-
Observation versus Resection for Small Asymptomatic Pancreatic Neuroendocrine Tumors: A Matched Case-Control Study..
23:1361-1370.
2016
-
Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020)..
23:722-728.
2016
-
Role of Adjuvant Radiotherapy in Locally Advanced Colonic Carcinoma in the Modern Chemotherapy Era..
23:856-862.
2016
-
Patients Treated at Low-Volume Centers have Higher Rates of Incomplete Resection and Compromised Outcomes: Analysis of 31,129 Patients with Papillary Thyroid Cancer..
23:403-409.
2016
-
Adrenal Imaging Features Predict Malignancy Better than Tumor Size..
22 Suppl 3:S721-S727.
2015
-
Evaluation of Adjuvant Radiation Therapy for Resected Gallbladder Carcinoma: A Multi-institutional Experience..
22 Suppl 3:S1100-S1106.
2015
-
Evaluation of Pathologic Nipple Discharge: What is the Added Diagnostic Value of MRI?.
22 Suppl 3:S435-S441.
2015
-
Percutaneous Preoperative Biliary Drainage for Resectable Perihilar Cholangiocarcinoma: No Association with Survival and No Increase in Seeding Metastases..
22 Suppl 3:S1156-S1163.
2015
-
FOLFIRINOX Induction Therapy for Stage 3 Pancreatic Adenocarcinoma..
22:3512-3521.
2015
-
[(99m)Tc]Tilmanocept Accurately Detects Sentinel Lymph Nodes and Predicts Node Pathology Status in Patients with Oral Squamous Cell Carcinoma of the Head and Neck: Results of a Phase III Multi-institutional Trial..
22:3708-3715.
2015
-
Positive postoperative CEA is a strong predictor of recurrence for patients after resection for colorectal liver metastases..
22:3087-3093.
2015
-
The use of radiation therapy in localized high-grade soft tissue sarcoma and potential impact on survival..
22:2831-2838.
2015
-
Recurrence After Partial Hepatectomy for Metastatic Colorectal Cancer: Potentially Curative Role of Salvage Repeat Resection..
22:2761-2771.
2015
-
Quality of life after isolated limb infusion for in-transit melanoma of the extremity..
22:1694-1700.
2015
-
Clinical features and outcome of primary pancreatic lymphoma..
22:1176-1184.
2015
-
Benefit of adjuvant chemotherapy after resection of stage II (T1-2N1M0) non-small cell lung cancer in elderly patients..
22:642-648.
2015
-
Burden of disease predicts response to isolated limb infusion with melphalan and actinomycin D in melanoma..
22:482-488.
2015
-
In-transit melanoma metastases: incidence, prognosis, and the role of lymphadenectomy..
22:358-360.
2015
-
Surgical patterns of care in patients with invasive breast cancer treated with neoadjuvant systemic therapy and breast magnetic resonance imaging: results of a secondary analysis of TBCRC 017..
22:75-81.
2015
-
A retrospective comparison of microwave ablation vs. radiofrequency ablation for colorectal cancer hepatic metastases..
21:4278-4283.
2014
-
Readmission after pancreatic resection: causes and causality pattern..
21:4342-4350.
2014
-
Predictors of hemodynamic instability during surgery for pheochromocytoma..
21:3865-3871.
2014
-
Robotic thyroidectomy for cancer in the US: patterns of use and short-term outcomes..
21:3859-3864.
2014
-
Impact of extent of surgery on survival in patients with small nonfunctional pancreatic neuroendocrine tumors in the United States..
21:3515-3521.
2014
-
Treatment patterns and outcomes for patients with adrenocortical carcinoma associated with hospital case volume in the United States..
21:3509-3514.
2014
-
Immunotherapy following regional chemotherapy treatment of advanced extremity melanoma..
21:2525-2531.
2014
-
Regional chemotherapy for unresectable intrahepatic cholangiocarcinoma: a potential role for dynamic magnetic resonance imaging as an imaging biomarker and a survival update from two prospective clinical trials..
21:2675-2683.
2014
-
Consensus guidelines from The American Society of Peritoneal Surface Malignancies on standardizing the delivery of hyperthermic intraperitoneal chemotherapy (HIPEC) in colorectal cancer patients in the United States..
21:1501-1505.
2014
-
Hypoxia in melanoma: using optical spectroscopy and EF5 to assess tumor oxygenation before and during regional chemotherapy for melanoma..
21:1435-1440.
2014
-
Prognostic significance of the highest peripancreatic lymph node in biliary tract adenocarcinoma..
21:979-985.
2014
-
SRC family kinase inhibition as a novel strategy to augment melphalan-based regional chemotherapy of advanced extremity melanoma..
21:1024-1030.
2014
-
Society of Surgical Oncology-American Society for Radiation Oncology consensus guideline on margins for breast-conserving surgery with whole-breast irradiation in stages I and II invasive breast cancer..
21:704-716.
2014
-
Treatment of extensive metastatic colorectal cancer to the liver with systemic and hepatic arterial infusion chemotherapy and two-stage hepatic resection: the role of salvage therapy for recurrent disease..
21:815-821.
2014
-
Floxuridine hepatic arterial infusion associated biliary toxicity is increased by concurrent administration of systemic bevacizumab..
21:479-486.
2014
-
Resection of residual disease after isolated limb infusion (ILI) is equivalent to a complete response after ILI-alone in advanced extremity melanoma..
21:650-655.
2014
-
Comparison between perioperative and postoperative chemotherapy after potentially curative hepatic resection for metastatic colorectal cancer..
20:4312-4321.
2013
-
Predicting dysplasia and invasive carcinoma in intraductal papillary mucinous neoplasms of the pancreas: development of a preoperative nomogram..
20:4348-4355.
2013
-
The cost-effectiveness of neoadjuvant chemoradiation is superior to a surgery-first approach in the treatment of pancreatic head adenocarcinoma..
20 Suppl 3:S500-S508.
2013
-
Prediction of disease-free survival in hepatocellular carcinoma by gene expression profiling..
20:3747-3753.
2013
-
Resident education in the era of patient safety: a nationwide analysis of outcomes and complications in resident-assisted oncologic surgery..
20:3715-3724.
2013
-
Geographic and temporal trends in the management of occult primary breast cancer: a systematic review and meta-analysis..
20:3308-3316.
2013
-
Incidentally discovered pancreatic intraepithelial neoplasia: what is its clinical significance?.
20:3643-3647.
2013
-
Outcome and prognostic factors after adrenalectomy for patients with distant adrenal metastasis..
20:3491-3496.
2013
-
Prevalence of BRCA mutations among women with triple-negative breast cancer (TNBC) in a genetic counseling cohort..
20:3254-3258.
2013
-
Conversion to complete resection and/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: a decade of experience at a single institution..
20:2901-2907.
2013
-
Perioperative complications influence recurrence and survival after resection of hepatic colorectal metastases..
20:2477-2484.
2013
-
Assessment of advanced gastric cancer management in the United States..
20:2124-2131.
2013
-
Frequency and intensity of postoperative surveillance after curative treatment of pancreatic cancer: a cost-effectiveness analysis..
20:2197-2203.
2013
-
Risk of occult irresectable disease at liver resection for hepatic colorectal cancer metastases: a contemporary analysis..
20:2029-2034.
2013
-
Plasma cytokine analysis in patients with advanced extremity melanoma undergoing isolated limb infusion..
20:1128-1135.
2013
-
Patient and process factors associated with late-stage breast cancer diagnosis in Safety-Net patients: a pilot prospective study..
20:723-732.
2013
-
Malignant progression in IPMN: a cohort analysis of patients initially selected for resection or observation..
20:440-447.
2013
-
Treatment trends and predictors of adjuvant and neoadjuvant therapy for gastric adenocarcinoma in the United States..
20:362-370.
2013
-
BRAF V600E mutation independently predicts central compartment lymph node metastasis in patients with papillary thyroid cancer..
20:47-52.
2013
-
Detailed pathologic characteristics of the primary colorectal tumor independently predict outcome after hepatectomy for metastases..
20:148-154.
2013
-
Hepatic pedicle clamping during hepatic resection for colorectal liver metastases: no impact on survival or hepatic recurrence..
20:285-294.
2013
-
Management and recurrence patterns of desmoids tumors: a multi-institutional analysis of 211 patients..
19:4036-4042.
2012
-
Synchronous resection of primary and liver metastases for neuroendocrine tumors..
19:4270-4277.
2012
-
The impact of vascular resection on early postoperative outcomes after pancreaticoduodenectomy: an analysis of the American College of Surgeons National Surgical Quality Improvement Program database..
19:4068-4077.
2012
-
A phase I multi-institutional study of systemic sorafenib in conjunction with regional melphalan for in-transit melanoma of the extremity..
19:3896-3905.
2012
-
Tumor proximity to the recurrent laryngeal nerve in patients with primary hyperparathyroidism undergoing parathyroidectomy..
19:3823-3826.
2012
-
Non-vena cava venous leiomyosarcomas: a review of the literature..
19:3368-3374.
2012
-
Outcomes after total skin-sparing mastectomy and immediate reconstruction in 657 breasts..
19:3402-3409.
2012
-
Presentation and management of gastrointestinal stromal tumors of the duodenum: a multi-institutional analysis..
19:3351-3360.
2012
-
Sentinel lymph node biopsy for melanoma: American Society of Clinical Oncology and Society of Surgical Oncology joint clinical practice guideline..
19:3313-3324.
2012
-
Impact of obesity and body fat distribution on survival after pancreaticoduodenectomy for pancreatic adenocarcinoma..
19:2908-2916.
2012
-
Pathologic response to preoperative chemotherapy in colorectal liver metastases: fibrosis, not necrosis, predicts outcome..
19:2797-2804.
2012
-
Patterns of recurrence following complete response to regional chemotherapy for in-transit melanoma..
19:2563-2571.
2012
-
Racial and gender disparities and the role of primary tumor type on inpatient outcomes following craniotomy for brain metastases..
19:2657-2663.
2012
-
Resection of adrenocortical carcinoma liver metastasis: is it justified?.
19:2643-2651.
2012
-
Simultaneous medullary and differentiated thyroid cancer: a population-level analysis of an increasingly common entity..
19:2635-2642.
2012
-
A pathway-based approach to identify molecular biomarkers in cancer..
19 Suppl 3:S620-S624.
2012
-
CXCR4 expression predicts patient outcome and recurrence patterns after hepatic resection for colorectal liver metastases..
19 Suppl 3:S339-S346.
2012
-
Putatively functional PLCE1 variants and susceptibility to esophageal squamous cell carcinoma (ESCC): a case-control study in eastern Chinese populations..
19:2403-2410.
2012
-
Aggressive variants of papillary thyroid cancer: incidence, characteristics and predictors of survival among 43,738 patients..
19:1874-1880.
2012
-
Ex vivo evaluation of preoperatively treated rectal cancer specimens of patients undergoing radical resection..
19:1954-1958.
2012
-
A multi-institutional experience of repeat regional chemotherapy for recurrent melanoma of extremities..
19:1637-1643.
2012
-
A population-based comparison of adenocarcinoma of the large and small intestine: insights into a rare disease..
19:1439-1445.
2012
-
Biliary sclerosis after hepatic arterial infusion pump chemotherapy for patients with colorectal cancer liver metastasis: incidence, clinical features, and risk factors..
19:1609-1617.
2012
-
Carcinoma of the ampulla of Vater: patterns of failure following resection and benefit of chemoradiotherapy..
19:1535-1540.
2012
-
Downstaging in pancreatic cancer: a matched analysis of patients resected following systemic treatment of initially locally unresectable disease..
19:1663-1669.
2012
-
Adjuvant radiotherapy in the treatment of invasive intraductal papillary mucinous neoplasm of the pancreas: an analysis of the surveillance, epidemiology, and end results registry..
19:1316-1323.
2012
-
Patterns of recurrence after ablation of colorectal cancer liver metastases..
19:834-841.
2012
-
Is port site resection necessary in the surgical management of gallbladder cancer?.
19:409-417.
2012
-
Survival after resection of pancreatic adenocarcinoma: results from a single institution over three decades..
19:169-175.
2012
-
Both BRAF V600E mutation and older age (≥ 65 years) are associated with recurrent papillary thyroid cancer..
18:3566-3571.
2011
-
Features associated with successful recruitment of diverse patients onto cancer clinical trials: report from the American College of Surgeons Oncology Group..
18:3544-3550.
2011
-
Significance of pathologic response to preoperative therapy in pancreatic cancer: the future ain't what it used to be..
18:3533-3534.
2011
-
Selective organ preservation in operable locally advanced head and neck squamous cell carcinomas guided by primary site restaging biopsy: long-term results of two sequential brown university oncology group chemoradiotherapy studies..
18:3479-3485.
2011
-
Adrenalectomy in older Americans has increased morbidity and mortality: an analysis of 6,416 patients..
18:2714-2721.
2011
-
Antiangiogenic therapy for primary liver cancer: correlation of changes in dynamic contrast-enhanced magnetic resonance imaging with tissue hypoxia markers and clinical response..
18:2192-2199.
2011
-
Standardizing regional therapy: developing a consensus on optimal utilization of regional chemotherapy treatments in melanoma..
18:1814-1818.
2011
-
Fluorouracil-based chemoradiation with either gemcitabine or fluorouracil chemotherapy after resection of pancreatic adenocarcinoma: 5-year analysis of the U.S. Intergroup/RTOG 9704 phase III trial..
18:1319-1326.
2011
-
Prospective evaluation of laparoscopic celiac plexus block in patients with unresectable pancreatic adenocarcinoma..
18:636-641.
2011
-
Pancreatic cyst fluid and serum mucin levels predict dysplasia in intraductal papillary mucinous neoplasms of the pancreas..
18:199-206.
2011
-
Adjuvant radiation therapy for distal pancreatic cancer: is there a role?.
17:3082-3084.
2010
-
Biobanking of human pancreas cancer tissue: impact of ex-vivo procurement times on RNA quality..
17:2229-2236.
2010
-
Inhibition of poly(ADP-ribose) polymerase enhances the effect of chemotherapy in an animal model of regional therapy for the treatment of advanced extremity malignant melanoma..
17:2247-2254.
2010
-
Serum CA 19-9 as a marker of resectability and survival in patients with potentially resectable pancreatic cancer treated with neoadjuvant chemoradiation..
17:1794-1801.
2010
-
Proton-beam, intensity-modulated, and/or intraoperative electron radiation therapy combined with aggressive anterior surgical resection for retroperitoneal sarcomas..
17:1515-1529.
2010
-
The adrenal mass: correlation of histopathology with imaging..
17:846-852.
2010
-
Prognostic impact of RT-PCR-based detection of peritoneal micrometastases in patients with pancreatic cancer undergoing curative resection..
16:3333-3339.
2009
-
Defining surgical indications for type I gastric carcinoid tumor..
16:3154-3160.
2009
-
Predictive factors of regional toxicity and serum creatine phosphokinase levels after isolated limb infusion for melanoma: a multi-institutional analysis..
16:2570-2578.
2009
-
Synchronous colorectal liver metastases: is it time to reconsider traditional paradigms of management?.
16:2395-2410.
2009
-
Response to neoadjuvant chemotherapy does not predict overall survival for patients with synchronous colorectal hepatic metastases..
16:1844-1851.
2009
-
Timing of multimodality therapy for resectable synchronous colorectal liver metastases: a retrospective multi-institutional analysis..
16:1809-1819.
2009
-
Laparoscopic versus open subtotal gastrectomy for adenocarcinoma: a case-control study..
16:1507-1513.
2009
-
Optimizing regional therapy for melanoma..
16:1095-1097.
2009
-
Optimizing melphalan pharmacokinetics in regional melanoma therapy: does correcting for ideal body weight alter regional response or toxicity?.
16:953-961.
2009
-
Polymorphisms of p16, p27, p73, and MDM2 modulate response and survival of pancreatic cancer patients treated with preoperative chemoradiation..
16:431-439.
2009
-
Molecular staging of pathologically negative sentinel lymph nodes from melanoma patients using multimarker, quantitative real-time rt-PCR..
16:177-185.
2009
-
Preoperative CA 19-9 and the yield of staging laparoscopy in patients with radiographically resectable pancreatic adenocarcinoma..
15:3512-3520.
2008
-
Impact of time duration after neoadjuvant therapy to surgery on response and outcome in rectal cancer patients..
15:2636-2638.
2008
-
A phase I trial of oxaliplatin for intraperitoneal hyperthermic chemoperfusion for the treatment of peritoneal surface dissemination from colorectal and appendiceal cancers..
15:2137-2145.
2008
-
Isolated limb infusion for in-transit malignant melanoma of the extremity: a well-tolerated but less effective alternative to hyperthermic isolated limb perfusion..
15:2195-2205.
2008
-
Development of an integrated biospecimen bank and multidisciplinary clinical database for pancreatic cancer..
15:1356-1366.
2008
-
A phase II prospective multi-institutional trial of adjuvant active specific immunotherapy following curative resection of colorectal cancer hepatic metastases: cancer and leukemia group B study 89903..
15:158-164.
2008
-
Simultaneous resections of colorectal cancer and synchronous liver metastases: a multi-institutional analysis..
14:3481-3491.
2007
-
Utility of a prognostic nomogram designed for gastric cancer in predicting outcome of patients with R0 resected duodenal adenocarcinoma..
14:3159-3167.
2007
-
Implications of HER2-targeted therapy on extent of surgery for early-stage breast cancer..
22:1404-1405.
2015
-
Cost implications of the SSO-ASTRO consensus guideline on margins for breast-conserving surgery with whole breast irradiation in stage I and II invasive breast cancer..
21:1512-1514.
2014
-
When a chance to cut is not a chance to cure: a future for palliative surgery?.
18:3235-3239.
2011
-
The Devil's in the Details: Discrepancy Between Biopsy Thickness and Final Pathology in Acral Melanoma.
2020
-
Germline Genetic Mutations in a Multi-center Contemporary Cohort of 550 Phyllodes Tumors: An Opportunity for Expanded Multi-gene Panel Testing.
2020
-
Is There a Role for Surgery in Patients with Neuroendocrine Tumors of the Esophagus? A Contemporary View from the NCDB.
2020
-
Efficacy of Talimogene Laherparepvec (T-VEC) Therapy in Patients with In-Transit Melanoma Metastasis Decreases with Increasing Lesion Size.
2019
-
DCIS with Microinvasion: Is It In Situ or Invasive Disease?
2019
-
Neoadjuvant Endocrine Therapy Versus Neoadjuvant Chemotherapy in Node-Positive Invasive Lobular Carcinoma.
2019
-
Perspectives on the Costs of Cancer Care: A Survey of the American Society of Breast Surgeons.
2019
-
Long-Term Oncologic Outcomes After Isolated Limb Infusion for Locoregionally Metastatic Melanoma: An International Multicenter Analysis.
2019
-
Axillary Nodal Evaluation in Elderly Breast Cancer Patients: Potential Effects on Treatment Decisions and Survival.
2018
-
Minimally Invasive Pancreaticoduodenectomy Does Not Improve Use or Time to Initiation of Adjuvant Chemotherapy for Patients With Pancreatic Adenocarcinoma.
2016
-
A national snapshot of satisfaction with breast cancer procedures.
2015
-
A multicenter phase I dose escalation trial to evaluate safety and tolerability of intra-arterial temozolomide for patients with advanced extremity melanoma using normothermic isolated limb infusion.
2015
-
Defining the learning curve for team-based laparoscopic pancreaticoduodenectomy.
2014
-
Surgical treatment of resectable and borderline resectable pancreatic cancer: expert consensus statement by Evans et al.
2009
-
Long-term survival after multidisciplinary management of resected pancreatic adenocarcinoma.
2009